PGS Sample Set (PSS) large_stringlengths 9 9 | Polygenic Score (PGS) ID large_stringlengths 9 2.77k | Number of Individuals int64 1 5.33M | Number of Cases float64 0 389k ⌀ | Number of Controls float64 0 1.14M ⌀ | Percent of Participants Who are Male float64 0 100 ⌀ | Sample Age large_stringclasses 733
values | Broad Ancestry Category large_stringclasses 73
values | Ancestry (e.g. French, Chinese) large_stringclasses 90
values | Country of Recruitment large_stringclasses 140
values | Additional Ancestry Description large_stringclasses 131
values | Phenotype Definitions and Methods large_stringclasses 798
values | Followup Time large_stringclasses 141
values | GWAS Catalog Study ID (GCST...) large_stringclasses 8
values | Source PubMed ID (PMID) float64 1.25M 39.9M ⌀ | Source DOI large_stringclasses 13
values | Cohort(s) large_stringclasses 460
values | Additional Sample/Cohort Information large_stringclasses 245
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PSS011678 | PGS000004 | 6,522 | 320 | 6,202 | 0 | mean:66.05;unit:years | European | Dutch | Netherlands | null | Cases include women that developed breast cancer. Within the cases there were 290 invasive breast cancer cases and 34 in situ breast cancer cases. | median:12.4;range:[0.03,24.43];unit:years | null | null | null | RS | null |
PSS011679 | PGS000013 | 80,865 | 382 | 80,483 | null | null | European | null | null | null | Cases were individuals who had experienced mycoardial injury after non-cardiac surgery (MINS). MINS was defined as a new troponin elevation (≥ 0.1 ng/mL, institutional laboratory's upper threshold for normal) occurring within the first 30 days after surgery. If a patient underwent a subsequent surgery within the 30-day... | null | null | null | null | MGI | null |
PSS011679 | PGS000013 | 4,614 | 25 | 4,589 | null | null | African unspecified | null | null | null | Cases were individuals who had experienced mycoardial injury after non-cardiac surgery (MINS). MINS was defined as a new troponin elevation (≥ 0.1 ng/mL, institutional laboratory's upper threshold for normal) occurring within the first 30 days after surgery. If a patient underwent a subsequent surgery within the 30-day... | null | null | null | null | MGI | null |
PSS011679 | PGS000013 | 1,121 | 4 | 1,117 | null | null | Asian unspecified, Oceanian | null | null | null | Cases were individuals who had experienced mycoardial injury after non-cardiac surgery (MINS). MINS was defined as a new troponin elevation (≥ 0.1 ng/mL, institutional laboratory's upper threshold for normal) occurring within the first 30 days after surgery. If a patient underwent a subsequent surgery within the 30-day... | null | null | null | null | MGI | null |
PSS011679 | PGS000013 | 304 | 3 | 301 | null | null | Native American | null | null | null | Cases were individuals who had experienced mycoardial injury after non-cardiac surgery (MINS). MINS was defined as a new troponin elevation (≥ 0.1 ng/mL, institutional laboratory's upper threshold for normal) occurring within the first 30 days after surgery. If a patient underwent a subsequent surgery within the 30-day... | null | null | null | null | MGI | null |
PSS011679 | PGS000013 | 3,149 | 15 | 3,134 | null | null | Not reported | null | null | null | Cases were individuals who had experienced mycoardial injury after non-cardiac surgery (MINS). MINS was defined as a new troponin elevation (≥ 0.1 ng/mL, institutional laboratory's upper threshold for normal) occurring within the first 30 days after surgery. If a patient underwent a subsequent surgery within the 30-day... | null | null | null | null | MGI | null |
PSS011680 | PGS000011, PGS000012 | 26,203 | 2,063 | 24,140 | 46.74 | mean:48.0;unit:years | European | Finnish | Finland | null | At baseline, all individuals were free from coronary heart disease (CHD). Cases included individuals who were hospitalised due to CHD or suffered a fatal CHD event. CHD events were defined for non-fatal cases as the International Classification of Diseases ninth revision (ICD-9) codes 410 and 4110 (years 1992-1995) and... | mean:13.8;unit:years | null | null | null | FINRISK | null |
PSS011681 | PGS000018, PGS000039 | 306,654 | 5,680 | 300,974 | 43.01 | mean:56.0;sd:8.0;unit:years | European | null | UK | null | The primary outcome was a first-onset cardiovascular disease event, defined as the composite of CHD (i.e., myocardial infarction or fatal CHD) or any stroke. Secondary outcomes included each of CHD and stroke separately, and a combination of CHD, stroke, and cardiac revascularisation procedures (i.e., percutaneous tran... | median:8.1;unit:years | null | null | null | UKB | null |
PSS011682 | PGS004899 | 412 | 28 | 384 | null | null | Not reported | null | null | null | All individuals had multifocal FMD. Cases show those with spontaneous coronary artery dissection. | null | null | null | null | CCGB | Cases from Cleveland Clinic FMD Biorepository |
PSS011683 | PGS004899 | 294,465 | 95,347 | 199,118 | null | null | European | null | null | null | An individual was classified as a case if he or she had ≥1 admission to a VA hospital with discharge diagnosis of acute myocardial infarction (AMI) or ≥1 procedure code for revascularization of the coronary arteries or ≥2 ICD codes for CAD (410-414) on ≥2 dates. | null | null | null | null | MVP | null |
PSS011684 | PGS004899 | 314,434 | 14,802 | 299,632 | null | null | European | null | null | null | Cases are individuals with evidence of hospitilisation for myocardial infarction. | null | null | null | null | MVP | null |
PSS011685 | PGS004899 | 373,056 | 15,476 | 357,580 | 45.86 | null | European | null | UK | null | MI events were defined pre- enrollment by self-reported medical history and post-enrollment by hospital epi- sode statistics using ICD, Version 10 diagnosis codes (I21, I22, I23, or I24). Events were censored on the date of loss to follow-up, death, or if individuals remained event free up to March 31, 2017. | null | null | null | null | UKB | null |
PSS011686 | PGS004901 | 2,576 | null | null | 0 | null | European | null | UK | null | Birth length (crown-heel) was measured by ALSPAC staff who visited newborns soon after birth (median 1 day, range 1-14 days), using a Harpenden Neonatometer (Holtain Ltd). Birth weight was extracted from medical records. From birth to five years, length and weight mea- surements were extracted from health visitor recor... | mean:20.0;unit:years | null | null | null | ALSPAC | null |
PSS011687 | PGS004900 | 2,690 | null | null | 100 | null | European | null | UK | null | Birth length (crown-heel) was measured by ALSPAC staff who visited newborns soon after birth (median 1 day, range 1-14 days), using a Harpenden Neonatometer (Holtain Ltd). Birth weight was extracted from medical records. From birth to five years, length and weight mea- surements were extracted from health visitor recor... | mean:20.0;unit:years | null | null | null | ALSPAC | null |
PSS011688 | PGS004902 | 10,180 | null | null | 45 | mean:51.8;unit:years | African unspecified | Continental Africans | Ghana, Burkina Faso, South Africa, Kenya | null | null | null | null | null | null | AWI-Gen | null |
PSS011689 | PGS000013 | 5,453 | 565 | 4,888 | 42.3 | mean:63.0;sd:5.7;unit:years | European | null | U.S. | null | null | mean:14.2;unit:years | null | null | null | ARIC | null |
PSS011690 | PGS000013 | 2,017 | 153 | 1,864 | 44.2 | mean:56.7;sd:9.2;unit:years | European | null | U.S. | null | null | mean:18.5;unit:years | null | null | null | FOS | null |
PSS011691 | PGS004903 | 3,212 | 88 | 3,124 | null | null | European | null | null | null | null | null | null | null | null | BSTOP | null |
PSS011692 | PGS004602 | 433,150 | null | null | null | null | European | British | U.K. | null | ICD-10 code, E11 | null | null | null | null | UKB | null |
PSS011693 | PGS000356 | 414 | 9 | 405 | null | null | African unspecified | null | null | null | null | null | null | null | null | SJLIFE|CCSS | null |
PSS011694 | PGS000356 | 4,322 | 259 | 4,063 | null | null | European | null | null | null | null | null | null | null | null | SJLIFE|CCSS | null |
PSS011695 | PGS000356 | 718 | null | null | 49.4 | null | African unspecified | null | null | null | null | null | null | null | null | SJLIFE|CCSS | null |
PSS011696 | PGS000356 | 9,895 | null | null | 49.8 | null | European | null | null | null | null | null | null | null | null | SJLIFE|CCSS | null |
PSS011697 | PGS004904 | 113,256 | null | null | null | null | European | null | UK | null | null | null | null | null | null | UKB | null |
PSS011698 | PGS000016, PGS000911 | 1,567 | null | null | null | null | European | null | null | null | null | null | null | null | null | EAST-AFNET4 | null |
PSS011699 | PGS000911 | 407,311 | null | null | null | null | European | null | null | null | null | null | null | null | null | UKB | null |
PSS011700 | PGS004905 | 375,776 | 17,096 | 358,680 | null | null | European | null | null | null | null | median:11.9;unit:years | null | null | null | UKB | null |
PSS011700 | PGS004905 | 9,703 | 252 | 9,451 | null | null | Not reported | null | null | null | null | median:11.9;unit:years | null | null | null | UKB | null |
PSS011700 | PGS004905 | 8,698 | 240 | 8,458 | null | null | Asian unspecified | null | null | null | null | median:11.9;unit:years | null | null | null | UKB | null |
PSS011700 | PGS004905 | 7,074 | 143 | 6,931 | null | null | African unspecified | null | null | null | null | median:11.9;unit:years | null | null | null | UKB | null |
PSS011701 | PGS004906, PGS004907 | 2,169 | null | null | 50.8 | median:6.0;95% range:[5.7,7.5];unit:years | European | null | null | null | null | null | null | null | null | Generation_R | null |
PSS011701 | PGS004906, PGS004907 | 3,382 | null | null | 52 | median:7.5;95% range:[7.3,8.9];unit:years | European | null | null | null | null | null | null | null | null | ALSPAC | null |
PSS011701 | PGS004906, PGS004907 | 1,680 | null | null | 49.3 | median:12.1;95% range:[12.0,12.5];unit:years | European | null | null | null | null | null | null | null | null | BLTS | null |
PSS011702 | PGS004908 | 324,805 | 1,696 | 323,109 | null | null | European | null | UK | null | null | null | null | null | null | UKB | null |
PSS011703 | PGS004909 | 196 | null | null | null | null | European | null | null | null | Participants were treatment seeking smokers. Using a nicotine metabolite ratio (NMR) cut-point of 0.31, individuals with slow nicotine metabolism were defined as having a NMR <0.31 whilst individuals with normal rates of nicotine metabolism were defined as having a NMR ≥0.31. Using a nicotine metabolite ratio (NMR) cut... | null | null | null | null | Q2L | null |
PSS011704 | PGS004910, PGS004911 | 343,182 | 366 | 342,816 | null | null | European | null | UK | null | null | null | null | null | null | UKB | null |
PSS011705 | PGS004912 | 24,322 | 6,609 | 17,713 | 55.6 | mean:62.07;sd:5.21;unit:years | European | null | U.S. | null | null | null | null | null | null | PLCO | null |
PSS011706 | PGS004912 | 2,344 | 672 | 1,672 | 46.72 | mean:57.59;sd:8.47;unit:years | East Asian | Chinese | China | null | null | null | null | null | null | ZJCRC | null |
PSS011707 | PGS000004 | 110,869 | 2,716 | 108,153 | 0 | null | European | null | UK | null | Cases are those of incident breast cancer. In UK Biobank, cancer diagnoses were ascertained through linkage to national cancer registries in England, Wales, and Scotland. Invasive breast cancer was coded using the 10th Revision of the International Classification of Diseases. Death was ascertained via linkage to death ... | null | null | null | null | UKB | null |
PSS011708 | PGS000004 | 35,457 | 706 | 34,751 | 0 | null | European | null | UK | null | Cases are those of incident breast cancer. In UK Biobank, cancer diagnoses were ascertained through linkage to national cancer registries in England, Wales, and Scotland. Invasive breast cancer was coded using the 10th Revision of the International Classification of Diseases. Death was ascertained via linkage to death ... | null | null | null | null | UKB | null |
PSS011709 | PGS004913 | 3,360 | 121 | 3,239 | null | null | European | null | US | null | null | null | null | null | null | IB-liver | null |
PSS011710 | PGS004913 | 3,709 | 470 | 3,239 | null | null | European | null | US | null | null | null | null | null | null | IB-liver | null |
PSS011711 | PGS004913 | 9,448 | 467 | 8,981 | null | null | European | null | UK | null | Cirrhosis cases were defined as having ICD10 code K70.3; “alcohol-associated cirrhosis of liver', or ICD-9 code 571.2, “Cirrhosis, liver, alcohol-associated or ICD10 code K70.1; “alcoholic hepatitis without ascites” or ICD-9 code 571.1, “acute alcoholic hepatitis.” Controls were defined as having (1) reported alcohol i... | null | null | null | null | UKB | null |
PSS011712 | PGS000740 | 1,123 | 558 | 565 | 43.5 | null | African unspecified | null | null | null | null | null | null | null | null | INHALE | null |
PSS011713 | PGS000740 | 1,915 | 1,103 | 812 | 47.2 | null | European | null | null | null | null | null | null | null | null | INHALE | null |
PSS011714 | PGS004914 | 357,202 | null | null | 46 | mean:57.0;unit:years | European | British | UK | null | null | null | null | null | null | UKB | null |
PSS011715 | PGS004915 | 389,564 | null | null | 46 | mean:57.0;unit:years | European | British | UK | null | null | null | null | null | null | UKB | null |
PSS011716 | PGS004914 | 407,558 | 29,600 | 377,958 | 46 | mean:57.0;unit:years | European | British | UK | null | Infectious disease-related hospitalizations by International Classification of Diseases (ICD) version 10 diagnosis codes included: sepsis (ICD-10 codes: A021 Salmonella septicemia, A227 Antrhrax septicemia, A40 Streptococcal septicemia, A41 Other septicemia, B377 Candidal septicemia, O85 Puerperal sepsis, R651 Systemic... | null | null | null | null | UKB | null |
PSS011717 | PGS004916 | 389,971 | null | null | 46 | mean:57.0;unit:years | European | British | UK | null | null | null | null | null | null | UKB | null |
PSS011718 | PGS004917 | 1,274 | 138 | 1,136 | 0 | null | European, Not reported | null | USA | European (98%) | Those indicating having received a new systemic lupus erythematosus diagnosis were asked to complete the Connective Tissue Disease Screening Question- naire (12) and to consent to the release of their medical records. Released medical records of all nurses who indicated experi- encing systemic lupus erythematosus symp... | null | null | null | null | NHS|NHS2 | null |
PSS011718 | PGS004917 | 2,671 | 535 | 2,136 | 9.7 | null | European, Asian unspecified, African unspecified, Not reported | null | USA | European (68.1%), Asian (4.9%), African (14.2%), Not reported (12.8%) | All patients diagnosed as having systemic lupus erythematosus in the PHB and included in this study met at least 4 of the 11 ACR 1997 updated classification criteria for systemic lupus erythematosus . Cases were identified as those individuals previously included in the Brigham and Women's Hospital Lupus Registry or t... | null | null | null | null | PHB | null |
PSS011719 | PGS004918 | 136 | 56 | 80 | 39 | null | European | null | null | null | Samples used in this study were extracted from autopsied brain tissue. Samples were taken from cognitively normal individuals witth a dementia rating of 0 (controls) and from late-onset Alzheimer's disease (LOAD) patients who had a clinical diagnosis of dementia due to AD and neuropathological confirmation of AD. | null | null | null | null | BfDR | null |
PSS011720 | PGS000011 | 23,594 | 17,254 | 6,340 | 38 | mean:58.0;sd:7.7;unit:years | Not reported | null | Sweden | null | Cases are individuals that were hospitilized at least once for any cause. | mean:17.8;sd:4.4;unit:years | null | null | null | MDC | null |
PSS011721 | PGS000011 | 23,594 | null | null | 38 | mean:58.0;sd:7.7;unit:years | Not reported | null | Sweden | null | Cases are individuals that were hospitilized at least once for a CVD event. The causes of hospitilization were classified according to ICD code as the main diagnosis at discharge. The most common causes of CVD hospitalizations were ischeamic heart disease (33%), stroke (23%), arterial fibrillation (15%) and congestive ... | mean:17.8;sd:4.4;unit:years | null | null | null | MDC | null |
PSS011722 | PGS000011 | 23,594 | null | null | 38 | mean:58.0;sd:7.7;unit:years | Not reported | null | Sweden | null | null | null | null | null | null | MDC | null |
PSS011723 | PGS004252 | 327,124 | 6,238 | 320,886 | 48.1 | mean:56.6;sd:8.03;unit:years | European | null | UK | null | null | null | null | null | null | UKB | null |
PSS011724 | PGS004920 | 193,819 | 3,832 | 189,987 | null | null | European | null | U.K. | null | null | null | null | null | null | UKB | null |
PSS011725 | PGS002254 | 24,960 | null | null | 46.5 | mean:59.1;sd:14.6;unit:years | European | null | null | null | null | null | null | null | null | HUNT | null |
PSS011726 | PGS002254 | 47,148 | null | null | 45.9 | mean:52.9;sd:15.8;unit:years | European | null | null | null | null | null | null | null | null | HUNT | null |
PSS011727 | PGS004921 | 307,151 | 9,847 | 297,304 | 46.1 | mean:57.4;sd:8.0;unit:years | European | null | UK | null | A participant was defined as a CAD case if he/she had at least one occurrence of International Classification of Diseases, 10th edition (ICD-10) codes I21-I25 (covering ischemic heart diseases) or at least one occurrence of the following codes in Office of Population Censuses and Surveys Classification of Interventions... | median:[0.0,8.4];unit:years | null | null | null | UKB | null |
PSS011728 | PGS004921 | 138,270 | 6,774 | 131,496 | 100 | mean:57.6;sd:8.1;unit:years | European | null | UK | null | A participant was defined as a CAD case if he/she had at least one occurrence of International Classification of Diseases, 10th edition (ICD-10) codes I21-I25 (covering ischemic heart diseases) or at least one occurrence of the following codes in Office of Population Censuses and Surveys Classification of Interventions... | median:[0.0,8.4];unit:years | null | null | null | UKB | null |
PSS011729 | PGS004921 | 168,881 | 3,073 | 165,808 | 0 | mean:57.2;sd:7.9;unit:years | European | null | UK | null | A participant was defined as a CAD case if he/she had at least one occurrence of International Classification of Diseases, 10th edition (ICD-10) codes I21-I25 (covering ischemic heart diseases) or at least one occurrence of the following codes in Office of Population Censuses and Surveys Classification of Interventions... | median:[0.0,8.4];unit:years | null | null | null | UKB | null |
PSS011730 | PGS004921 | 317,509 | 10,358 | 307,151 | 46.1 | mean:57.4;sd:8.0;unit:years | European | null | UK | null | A participant was defined as a CAD case if he/she had at least one occurrence of International Classification of Diseases, 10th edition (ICD-10) codes I21-I25 (covering ischemic heart diseases) or at least one occurrence of the following codes in Office of Population Censuses and Surveys Classification of Interventions... | median:[0.0,8.4];unit:years | null | null | null | UKB | null |
PSS011731 | PGS004921 | 146,246 | 7,976 | 138,270 | 100 | mean:57.6;sd:8.1;unit:years | European | null | UK | null | A participant was defined as a CAD case if he/she had at least one occurrence of International Classification of Diseases, 10th edition (ICD-10) codes I21-I25 (covering ischemic heart diseases) or at least one occurrence of the following codes in Office of Population Censuses and Surveys Classification of Interventions... | median:[0.0,8.4];unit:years | null | null | null | UKB | null |
PSS011732 | PGS004921 | 171,263 | 2,382 | 168,881 | 0 | mean:57.2;sd:7.9;unit:years | European | null | UK | null | A participant was defined as a CAD case if he/she had at least one occurrence of International Classification of Diseases, 10th edition (ICD-10) codes I21-I25 (covering ischemic heart diseases) or at least one occurrence of the following codes in Office of Population Censuses and Surveys Classification of Interventions... | median:[0.0,8.4];unit:years | null | null | null | UKB | null |
PSS011733 | PGS004909, PGS004922 | 1,187 | null | null | null | null | African American or Afro-Caribbean, Sub-Saharan African, European | null | null | African American or Afro-Caribbean and Sub-Saharan African = 954, European = 933 | Participants were smokers. | null | null | null | null | PNAT2|KIS3 | null |
PSS011734 | PGS004922 | 216 | 216 | null | null | null | African unspecified | null | USA | null | Combination of heavy and light smokers. | null | null | null | null | Q2L | null |
PSS011735 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS003867, PGS004923 | 44,346 | 5,663 | 38,683 | null | null | African unspecified | null | U.S. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | T2D cases were ascertained based on a combination of hospital diagnosis codes, prescription medication, and lab results from blood tests occurring prior to baseline assessment. Participants were considered controls if they had no history of any diabetes diagnoses, T2D medication, or abnormal glucose or HbA1c lab result... | null | null | null | null | AllofUs | null |
PSS011736 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS003867, PGS004923 | 33,652 | 4,033 | 29,619 | null | null | Hispanic or Latin American | null | U.S. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | T2D cases were ascertained based on a combination of hospital diagnosis codes, prescription medication, and lab results from blood tests occurring prior to baseline assessment. Participants were considered controls if they had no history of any diabetes diagnoses, T2D medication, or abnormal glucose or HbA1c lab result... | null | null | null | null | AllofUs | null |
PSS011737 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS003867, PGS004923 | 109,021 | 10,069 | 98,952 | null | null | European | null | U.S. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | T2D cases were ascertained based on a combination of hospital diagnosis codes, prescription medication, and lab results from blood tests occurring prior to baseline assessment. Participants were considered controls if they had no history of any diabetes diagnoses, T2D medication, or abnormal glucose or HbA1c lab result... | null | null | null | null | AllofUs | null |
PSS011738 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS003867, PGS004923 | 38,941 | 726 | 38,215 | null | null | European | null | U.K. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | T2D was defined using ICD-10 codes E10-E14, G59.0, G63.2, H28.0, H36.0, M14.2, N08.3, or O24.0-O24.3. Participants with any diabetes history were excluded from analysis. Incident diabetes events were treated as incident T2D | null | null | null | null | INTERVAL | null |
PSS011739 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS003867, PGS004923 | 870 | 187 | 683 | null | null | South East Asian | Malay Singaporean | Singapore | Ancestry label assigned based on Malay being the majority reported ethnicity within the genetic cluster | Incident T2D was ascertained through a combination of linkage to national healthcare records, self-reported medical history at follow-up assessment (either diagnosis from a primary care physician or current diabetes medication usage), or with blood biomarker concentrations indicative of diabetes following the American ... | null | null | null | null | SingaporeMEC | null |
PSS011740 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS003867, PGS004923 | 1,149 | 205 | 944 | null | null | East Asian | Chinese Singaporean | Singapore | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | Incident T2D was ascertained through a combination of linkage to national healthcare records, self-reported medical history at follow-up assessment (either diagnosis from a primary care physician or current diabetes medication usage), or with blood biomarker concentrations indicative of diabetes following the American ... | null | null | null | null | SingaporeMEC | null |
PSS011741 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS003867, PGS004923 | 852 | 194 | 658 | null | null | South Asian | Indian Singaporean | Singapore | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | Incident T2D was ascertained through a combination of linkage to national healthcare records, self-reported medical history at follow-up assessment (either diagnosis from a primary care physician or current diabetes medication usage), or with blood biomarker concentrations indicative of diabetes following the American ... | null | null | null | null | SingaporeMEC | null |
PSS011742 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS004923 | 6,019 | 395 | 5,624 | null | null | African unspecified | null | U.K. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | Prevalent T2D status at baseline was adjudicated from a combination of retrospective hospital episode records, self-reported history of diabetes, and baseline medication using the Eastwood et al. algorithms. Incident T2D cases were ascertained following the Eastwood et al. algorithms on the basis of ICD-10 diagnosis co... | null | null | null | null | UKB | null |
PSS011743 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS004923 | 6,871 | 766 | 6,105 | null | null | African unspecified | null | U.K. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | Prevalent T2D status at baseline was adjudicated from a combination of retrospective hospital episode records, self-reported history of diabetes, and baseline medication using the Eastwood et al. algorithms. Incident T2D cases were ascertained following the Eastwood et al. algorithms on the basis of ICD-10 diagnosis co... | null | null | null | null | UKB | null |
PSS011744 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS004923 | 1,350 | 37 | 1,313 | null | null | East Asian | null | U.K. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | Prevalent T2D status at baseline was adjudicated from a combination of retrospective hospital episode records, self-reported history of diabetes, and baseline medication using the Eastwood et al. algorithms. Incident T2D cases were ascertained following the Eastwood et al. algorithms on the basis of ICD-10 diagnosis co... | null | null | null | null | UKB | null |
PSS011745 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS004923 | 1,432 | 76 | 1,356 | null | null | East Asian | null | U.K. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | Prevalent T2D status at baseline was adjudicated from a combination of retrospective hospital episode records, self-reported history of diabetes, and baseline medication using the Eastwood et al. algorithms. Incident T2D cases were ascertained following the Eastwood et al. algorithms on the basis of ICD-10 diagnosis co... | null | null | null | null | UKB | null |
PSS011746 | PGS000014, PGS000036, PGS001357, PGS001781, PGS002243, PGS004923 | 232,808 | 6,016 | 226,792 | null | null | European | null | U.K. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | Prevalent T2D status at baseline was adjudicated from a combination of retrospective hospital episode records, self-reported history of diabetes, and baseline medication using the Eastwood et al. algorithms. Incident T2D cases were ascertained following the Eastwood et al. algorithms on the basis of ICD-10 diagnosis co... | null | null | null | null | UKB | null |
PSS011747 | PGS000014, PGS000036, PGS001357, PGS001781, PGS002243, PGS004923 | 245,177 | 11,080 | 234,097 | null | null | European | null | U.K. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | Prevalent T2D status at baseline was adjudicated from a combination of retrospective hospital episode records, self-reported history of diabetes, and baseline medication using the Eastwood et al. algorithms. Incident T2D cases were ascertained following the Eastwood et al. algorithms on the basis of ICD-10 diagnosis co... | null | null | null | null | UKB | null |
PSS011748 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS004923 | 5,685 | 513 | 5,172 | null | null | South Asian | null | U.K. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | Prevalent T2D status at baseline was adjudicated from a combination of retrospective hospital episode records, self-reported history of diabetes, and baseline medication using the Eastwood et al. algorithms. Incident T2D cases were ascertained following the Eastwood et al. algorithms on the basis of ICD-10 diagnosis co... | null | null | null | null | UKB | null |
PSS011749 | PGS000014, PGS000036, PGS000330, PGS000713, PGS000729, PGS000805, PGS000864, PGS000868, PGS001357, PGS001781, PGS001818, PGS002026, PGS002243, PGS002671, PGS002771, PGS002780, PGS003103, PGS003443, PGS003444, PGS003445, PGS004923 | 6,992 | 1,253 | 5,739 | null | null | South Asian | null | U.K. | Ancestry label assigned based on genetic similarity with 1000 Genomes reference panel superpopulations | Prevalent T2D status at baseline was adjudicated from a combination of retrospective hospital episode records, self-reported history of diabetes, and baseline medication using the Eastwood et al. algorithms. Incident T2D cases were ascertained following the Eastwood et al. algorithms on the basis of ICD-10 diagnosis co... | null | null | null | null | UKB | null |
PSS011750 | PGS004924 | 3,482 | 72 | 3,410 | 0 | null | European, African unspecified, Not reported | null | U.S. | null | null | null | null | null | null | SISTER | null |
PSS011751 | PGS004924 | 3,482 | 456 | 3,026 | 0 | null | European, African unspecified, Not reported | null | U.S. | null | null | null | null | null | null | SISTER | null |
PSS011752 | PGS002262 | 39,164 | null | null | 42.4 | mean:53.9;sd:10.5;unit:years | East Asian | Chinese | China | null | null | median:11.6;unit:years | null | null | null | CIMIC|InterASIA|ChinaMUCA-1998 | null |
PSS011753 | PGS000662 | 3,368 | 1,162 | 2,206 | 100 | null | European | null | U.S. | null | null | null | null | null | null | AHS | null |
PSS011754 | PGS000662 | 2,794 | 588 | 2,206 | 100 | null | European | null | U.S. | null | null | null | null | null | null | AHS | null |
PSS011755 | PGS004925 | 77,500 | null | null | 43.2 | mean:56.3;sd:7.7;unit:years | European | British | U.K. | null | null | null | null | null | null | UKB | null |
PSS011756 | PGS004926 | 2,654 | null | null | null | null | European | null | U.K. | null | null | null | null | null | null | TwinsUK | Lower back pain prevalence = 28% |
PSS011757 | PGS004926 | 120,217 | 21,543 | 98,674 | null | null | European | null | U.K. | null | null | null | null | null | null | UKB | Chronic back pain prevalence = 18% |
PSS011758 | PGS002262 | 34,111 | null | null | 41.8 | mean:52.3;sd:10.5;unit:years | East Asian | Chinese | China | null | null | median:11.7;unit:years | null | null | null | CIMIC|InterASIA|ChinaMUCA-1998 | null |
PSS011759 | PGS004927 | 4,394 | null | null | 48 | mean:65.0;unit:years | European | null | U.K. | null | null | null | null | null | null | UKB | UK Biobank imaging participants, validation set |
PSS011760 | PGS004928 | 62,314 | 10,684 | 51,630 | null | null | East Asian | Korean | South Korea | null | We used criteria defined by AHA/NHLBI was used to define MetS for individuals in KoGES. The criteria are as follows: elevated waist circumference (Asian with WCmen ≥90 cm and WCwomen ≥80 cm, elevated TG (TG ≥150 mg/dL), sex-specific reduced HDL-C (HDL-Cmen <40 mg/dL and HDL-Cwomen <50 mg/dL), elevated blood pressure (s... | null | null | null | null | KoGES | null |
PSS011761 | PGS004928 | 11,139 | 4,641 | 6,498 | null | null | European | null | United Kingdom | null | We assigned the dichotomous MetS status based on AHA/NHLBI that consists of five criteria as follows: population- and sex-specific elevated waist circumference (WC, European with WCmen ≥102 cm and WCwomen ≥88 cm), elevated triglycerides (TG, TG ≥150 mg/dL), sex-specific reduced high-density lipoprotein cholesterol (HDL... | null | null | null | null | UKB | null |
PSS011762 | PGS000023, PGS000882, PGS002066, PGS003103, PGS003446, PGS004929, PGS004930, PGS004931, PGS004932, PGS004933, PGS004934, PGS004935, PGS004936, PGS004937 | 8,417 | null | null | null | null | European | null | USA | null | null | null | null | null | null | BBofA | null |
PSS011763 | PGS004938 | 7,124 | 724 | 6,400 | null | null | European | null | Russian Federation | null | Very severe respiratory confirmed covid vs. not severe respiratory confirmed covid | null | null | null | null | Genotek | null |
PSS011772 | PGS004941 | 72,149 | null | null | 40.2 | mean:51.7;sd:10.5;unit:years | East Asian | Chinese | China | null | Including death resulting from ischemic heart disease [ICD10: I20-I25], nonfatal myocardial infarction [ICD10: I21-I23], and coronary revascularization | median:12.2;unit:years | null | null | null | CKB | null |
PSS011773 | PGS004943 | 72,149 | null | null | 40.2 | mean:51.7;sd:10.5;unit:years | East Asian | Chinese | China | null | ICD10: I61 | median:12.2;unit:years | null | null | null | CKB | null |
PSS011774 | PGS004942 | 72,149 | null | null | 40.2 | mean:51.7;sd:10.5;unit:years | East Asian | Chinese | China | null | ICD10: I63 | median:12.2;unit:years | null | null | null | CKB | null |
PSS011775 | PGS000018 | 190,489 | null | null | null | null | European | null | UK | null | null | null | null | null | null | UKB | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.